Welcome to our dedicated page for Applied UV news (Ticker: AUVI), a resource for investors and traders seeking the latest updates and insights on Applied UV stock.
Applied UV, Inc. (AUVI) delivers innovative UV-based disinfection systems and custom mirror solutions for healthcare and hospitality sectors. This page provides investors and industry professionals with direct access to official announcements, financial updates, and strategic developments from the company.
Find timely updates on product launches, regulatory milestones, and partnership agreements that shape AUVI’s position in smart building technology and infection control markets. Content includes earnings reports, technology patents, and market expansion initiatives, offering insights into the company’s operational priorities.
Bookmark this page to stay informed about AUVI’s advancements in automated sterilization systems and decorative mirror designs. Regular updates ensure you never miss critical information affecting the company’s performance across global healthcare and hospitality markets.
Applied UV, Inc. (NASDAQ: AUVI) announced an upcoming investor conference call and live webcast on
Applied UV has announced purchase orders worth
Applied UV, Inc. (NASDAQ: AUVI) has announced a cash dividend of
Applied UV, Inc. (AUVI) is investigating potential illegal short selling of its stock, which may impact market integrity. The company has retained Herrick Feinstein LLP and Oyster Consulting to assist in this investigation. CEO Max Munn emphasized the commitment to protect shareholders from illegal trading practices and highlighted the expertise of the consulting team, including former regulatory officials. The investigation aims to ensure transparency and accountability in the trading of AUVI's shares, as such practices could undermine investor trust and the company's financial health.
Applied UV, Inc. (NASDAQ: AUVI) partners with Johnson Controls (NYSE: JCI) and Ushio America, Inc. to explore the efficacy of Far-UVC pathogen deactivation technology. This collaboration aims to assess both the effectiveness of the technology and any potential negative impacts on surrounding air quality. Initiated by leading U.S. universities and certified labs, the study is expected to commence within 3-6 months, with results shared publicly. The research highlights the potential benefits for various sectors including healthcare and education, and could significantly enhance indoor air quality operations.
Johnson Controls (NYSE: JCI) has announced a research collaboration with PURO Lighting, LLC, a subsidiary of Applied UV, Inc. (NASDAQ: AUVI), and Ushio America, Inc. to study the efficacy and safety of filtered far UV-C disinfection technology. The research, set to be conducted by leading U.S. universities and certified laboratories over the next 3-6 months, aims to assess pathogen inactivation effects on indoor air quality. Brian Stern of PURO highlighted the potential market benefits, including improved health and safety in workplaces. Results will be publicly shared to aid customer decisions and inform public policy.
Applied UV, Inc. (AUVI) has engaged Herrick, Feinstein LLP to investigate potential illegal short selling of its stock. The company suspects illegal trading practices that could harm its market integrity. CEO Max Munn expressed concerns over the situation and stated that the firm aims to protect both the company and its shareholders. Herrick Feinstein will be led by Howard Elisofon, a prominent litigator and former SEC attorney. Applied UV utilizes UVC and catalytic bioconversion technology for air purification, serving high-profile clients including Kaiser Permanente and the U.S. Department of Veterans Affairs.
Applied UV, Inc. (AUVI) has successfully completed mergers with Puro Lighting, LLC and LED Supply Co., which are projected to generate combined annualized sales of approximately
Applied UV, Inc. (NASDAQ: AUVI) announced a cash dividend of $0.21875 per share for holders of its 10.5% Series A Cumulative Perpetual Preferred Stock (NASDAQ: AUVIP). This dividend is set for payment on or about February 15, 2023, to shareholders on record as of February 3, 2023. The company specializes in pathogen elimination technology, utilizing narrow-range UVC light for effective surface area and air purification. Its subsidiaries, including SteriLumen, offer advanced products to combat infections across various sectors, including healthcare and commercial environments.
Applied UV Inc. (AUVI) has received an order exceeding